Search results
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 3 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 2 days agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks· 3 days agoShares of COVID-19 vaccine developers rose on Monday after the FDA issued briefing documents for its Vaccines and Related Biological ...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 3 days agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Co-Locating COVID Vaccines, Infection Testing With Syringe Services Shows Success
MedPage Today· 4 days ago...across 10 co-located clinics participating in the Baltimore City Health Department Syringe...
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 2 days agoThe booster shot will be available at a clinic from 1 p.m. to 7 p.m. at the Harlingen Health...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 7 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 7 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 7 days agoSeagen drugs contributed $742 million to the top line in the first quarter. Revenues from Pfizer’s...
Novavax's stock surges almost 300% in the past month
AOL· 16 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...